Dexium has been conceived with the joined forces from clinicians, researchers, data scientists and software engineers to create the next generation digital health solutions, with the end goal to achieve better patient outcomes and smarter engagement of physicians. With its award winning products including “KYT Adhere” (Prescription Digital Therapeutics) and “OncoWitz” (Oncologists Engagement Platform), Dexium has already created a name in the digital medicine space, while working with pharmaceuticals, hospitals, insurers and corporates.